Telix Pharmaceuticals Hosts Major PSMA Imaging Webinar as Prostate Cancer Focus Sharpens
Telix Pharmaceuticals announces March 2026 webinar on PSMA-PET/CT imaging innovations, featuring leading oncology experts discussing prostate cancer detection advances.
TLXradiopharmaceuticalsinvestor relations
